Risk of severe upper gastrointestinal complications among oral bisphosphonate users.

BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. AIM: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by mean...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Arianna Ghirardi, Lorenza Scotti, Antonella Zambon, Gianluca Della Vedova, Luca Cavalieri D'oro, Francesco Lapi, Francesco Cipriani, Achille P Caputi, Alberto Vaccheri, Dario Gregori, Rosaria Gesuita, Annarita Vestri, Tommaso Staniscia, Giampiero Mazzaglia, Giovanni Corrao, BEST Investigators
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science (PLoS) 2013-01-01
Col·lecció:PLoS ONE
Accés en línia:http://europepmc.org/articles/PMC3857168?pdf=render
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars